Purchase Order 75N98026P00621
Award Date 6/1/26
Potential Completion Date 9/30/26
Potential Value $615K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $691,214.50 firm-fixed-price delivery order to One Lambda, Inc., a for-profit manufacturer of medical testing reagents and supplies. The contract is for the delivery of various human leukocyte antigen (HLA) typing and antibody screening reagents used in diagnostics, research protocols, and maintaining accreditation at the NIH Clinical Center. One Lambda is a subsidiary of Thermo Electron...
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $636,690.50 firm fixed price delivery order contract to One Lambda, Inc. for various human leukocyte antigen typing and antibody screening reagents. One Lambda, Inc. is a subsidiary of Thermo Electron Corporation Financial Services Division and will perform the contract from its location in Canoga Park, California. The contract runs from July 29, 2021 through July 31, 2022 to provide products...
- The National Institutes of Health Clinical Center has awarded a $62,272.84 firm fixed-price purchase order to One Lambda, Inc. for HistoTrac software maintenance and human leukocyte antigen (HLA) database maintenance services. The contract runs from December 15, 2025 through December 14, 2026, with the place of performance located in Bethesda, Maryland. This award was made through open competition without set-aside designation. One Lambda, Inc., a subsidiary of Thermo Electron Corporation...
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $619,951 delivery order contract to One Lambda, Inc. for various hematology and serology reagents. One Lambda will provide typing and antibody screening reagents to support the NIH Clinical Center's medical testing programs. As the prime contractor, One Lambda will draw from their parent company Thermo Electron Corporation Financial Services Division to fulfill delivery of the reagents through...
- The Department of Health and Human Services National Institutes of Health Clinical Center (HHS-NIH) awarded a $677,035.53 firm fixed price delivery order contract to One Lambda Inc., a subsidiary of Thermo Electron Corporation Financial Services Division, to provide various reagents from August 1, 2023 through July 31, 2024. The place of performance will be One Lambda's facility located in Canoga Park, California. No subcontractors were identified. The reagents will likely support medical...
- This is a firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) to One Lambda, Inc., a subsidiary of Thermo Electron Corporation, for the supply of a LABScan 3D instrument, an advanced multiplex analyzer, to be used by the NIH Human Leukocyte Antigen (HLA) Laboratory. The purchase order, valued at $75,859.17, is being made on a sole-source basis under the authority of FAR Subpart 13.106-1(b)(i) due to the need for compatibility with the lab's existing procedures...
- The Department of Health and Human Services' National Institutes of Health Clinical Center awarded a firm fixed price purchase order to Omixon, Inc., a foreign-owned for-profit organization, for the supply of various biomedical products and services related to HLA genotyping. The contract, valued at $168,525.00, includes the delivery of Holotype HLA 24/11 kits, Promega GoTaq Long PCR Master Mix, and HLA Twin software to support the Clinical Center's research and development activities in HLA...
- The Department of Health and Human Services' National Institutes of Health Clinical Center awarded a firm fixed-price purchase order to Omixon, Inc., a foreign-owned for-profit organization, to provide reagents in support of the NIH Clinical Center's research and development activities related to HLA testing and transplantation. The contract, valued at $101,220.00, did not utilize any set-aside programs. Omixon, as the prime contractor, has previously provided the NIH Clinical Center with...
- This firm-fixed-price federal contract award to One Lambda, Inc., a for-profit manufacturer of medical diagnostic products, has a ceiling value of $126,615.06. The contract was issued by the Department of Health and Human Services (HHS) Office of the Chief Operating Officer and is not designated as a set-aside. The contract provides a range of products and services to support biomedical research, clinical care, and public health programs across various federal agencies, including the National...
- <p>The National Institutes of Health Clinical Center issued a delivery order to Immucor Inc. on January 18, 2026, with a ceiling value of $11,053.97 under GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests.</p> <p>Place of performance is Bethesda, MD 20892. The order is firm fixed price with an ultimate completion date of January 31, 2026. No set-aside was used.</p>
The NIH Clinical Center awarded a purchase order to One Lambda, Inc. valued at $615,447.36 on June 1, 2026, for HLA typing and antibody screening reagents to support the HLA Lab on a regular basis. Place of performance is Bethesda, Maryland. The order carries a firm fixed price and ultimate completion date of September 30, 2026. No set-aside was used.
Generated 5/30/26, 10:56 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $615.4k | 5/28/26 |